About Icons

Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

Drug Description in Trials / DrugBank / KEGG DRUG

Search results

No.

Drug (Description in trials)

DrugBank

KEGG DRUG

KEGG GENES

KEGG PATHWAY

Disease ID

1

Corticotropin
(D00146)

[1] Corticotropin

[2] Corticotropin (D00146),
Corticotropin, repository 💬

[1] MC2R 💬

[6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬

[10] 2, 13, 46, 75, 78, 81, 84, 145, 205, 222 💬

Disease ID	Name
2	Amyotrophic lateral sclerosis
13	Multiple sclerosis/Neuromyelitis optica
46	Malignant rheumatoid arthritis
75	Cushing disease
78	Hypopituitarism
81	Congenital adrenal hyperplasia
84	Sarcoidosis
145	West syndrome
205	Fragile X syndrome related disease
222	Primary nephrotic syndrome

2

Corticotropin-Releasing Hormone
(D00146)

[1] Corticotropin

[2] Corticotropin (D00146),
Corticotropin, repository 💬

[1] MC2R 💬

[6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬

[1] 205 💬

3

Crinecerfont is a novel non-peptide selective corticotropin releasing factor 1 (CRF1 ) receptor antagonist.
(D00146)

[2] Corticotropin,
Crinecerfont

[3] Corticotropin (D00146),
Corticotropin, repository ,
Crinecerfont 💬

[2] CRHR1,
MC2R 💬

[7] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬

[1] 81 💬

4

H.P. Acthar Gel (repository corticotropin injection)
(D00146)

[1] Corticotropin

[2] Corticotropin (D00146),
Corticotropin, repository 💬

[1] MC2R 💬

[6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬

[1] 13 💬

5

Other: corticotropin releasing hormone (CRH)
(D00146)

[1] Corticotropin

[2] Corticotropin (D00146),
Corticotropin, repository 💬

[1] MC2R 💬

[6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬

[1] 78 💬

6

Ovine Corticotropin-Releasing Hormone (oCRH)
(D00146)

[1] Corticotropin

[2] Corticotropin (D00146),
Corticotropin, repository 💬

[1] MC2R 💬

[6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬

[1] 75 💬

7

Repository Corticotropin Injection
(D00146)

[1] Corticotropin

[2] Corticotropin (D00146),
Corticotropin, repository 💬

[1] MC2R 💬

[6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬

[5] 2, 13, 46, 84, 222 💬

8

Repository Corticotropin Injection -Treatment Extension
(D00146)

[1] Corticotropin

[2] Corticotropin (D00146),
Corticotropin, repository 💬

[1] MC2R 💬

[6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬

[1] 84 💬